Ignite Creation Date:
2024-05-05 @ 11:21 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01318421
Status:
TERMINATED
Last Update Posted:
2015-12-14
First Post:
2011-03-08
Brief Title:
A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
Sponsor:
Elan Pharmaceuticals
Organization:
Elan Pharmaceuticals
Organization Data
Organization:
Elan Pharmaceuticals
Class:
INDUSTRY
Study ID:
ELND002-MS153
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Elan Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None